There are many treatment options for myelofibrosis patients to consider because cases can vary for everyone. The treatment decision will be made by the doctor after considering several factors that include age, symptoms, and which type of blood cells are being affected.
Myelofibrosis belongs to a group of blood disorders called Myeloproliferative Neoplasms (MPNs) that cause scarring of the bone marrow due to abnormal production of red blood cells, white blood cells, and platelets. Tests for blood and bone marrow can be used to diagnose any of the six MPNs, which include:
- Chronic myelogenous leukemia
- Polycythemia vera
- Primary myelofibrosis
- Essential thrombocythemia
- Chronic neutrophilic leukemia
- Chronic eosinophilic leukemia